Carbon monoxide: a novel pulmonary artery vasodilator in neonatal llamas of the Andean altiplano
Artículo
Publication date
2008Metadata
Show full item record
Cómo citar
Herrera Videla, Emilio
Cómo citar
Carbon monoxide: a novel pulmonary artery vasodilator in neonatal llamas of the Andean altiplano
Author
- Herrera Videla, Emilio;
- Reyes, Roberto V.;
- Giussani, Dino A.;
- Riquelme González, Raquel;
- Sanhueza Reinoso, Emilia;
- Ebensperger Darrouy, Germán;
- Casanello, Paola;
- Méndez, Natalia;
- Ebensperger, Renato;
- Sepúlveda Kattan, Esteban;
- Pulgar, Víctor M.;
- Cabello, Gertrudis;
- Blanco, Carlos E.;
- Hanson, Mark A.;
- Parer, Julian T.;
- Llanos Mansilla, Jorge;
Abstract
Aims To study the nitric oxide (NO) and carbon monoxide roles in the regulation of the pulmonary
circulation in lowland and highland newborn sheep and llamas.
Methods and results We used neonatal sheep (Ovis aries) and llamas (Lama glama) whose gestation and
delivery took place at low (580 m) or high (3600 m) altitude. In vivo, we measured the cardiopulmonary
function basally and with a NO synthase (NOS) blockade and calculated the production of carbon monoxide
by the lung. In vitro, we determined NOS and soluble guanylate cyclase (sGC) expression, NOS
activity, and haemoxygenase (HO) expression in the lung. Pulmonary arterial pressure was elevated
at high altitude in sheep but not in llamas. Sheep at high altitude relative to sea level had significantly
greater total lung NOS activity and eNOS protein, but reduced sGC and HO expression and carbon monoxide
production. In contrast, llamas showed no difference in NO function between altitudes, but a pronounced
increase in pulmonary carbon monoxide production and HO expression at high altitude.
Conclusions In the llama, enhanced pulmonary carbon monoxide, rather than NO, protects against pulmonary
hypertension in the newborn period at high altitude. This shift in pulmonary dilator strategy
from NO to carbon monoxide has not been previously described, and it may give insight into new treatments
for excessive pulmonary vasoconstriction.
Patrocinador
This work was funded by the Fondo Nacional de Ciencia y
Tecnologı´a (FONDECYT), Chile, Grant 1050479 and The Wellcome
Trust Collaborative Research Initiative (CRIG), UK,
Grant 072256. E.A.H. was a Fellow of Programa de Mejoramiento
de la Calidad y la Equidad de la Educacio´n Superior
(MECESUP), Chile, Grant UCh0115 and Beca Universidad de
Chile, Grant PG/54/2005 (PhD programme).
Quote Item
Cardiovascular Research (2008) 77, 197–201
Collections